Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

58105 Results Found

FCC makes additional funding available for Rural Health Care Program

The Federal Communications Commission’s Rural Health Care Program will carry forward up to $379.97 million in unused funds from prior years to increase available funding for funding year 2021 and beyond if needed, the agency announced.

House holds hearing on legislation to improve public health

The House Energy and Commerce Committee held a hearing on several AHA-supported bills to advance public health by focusing on social determinants of health and data collection.
Public

Amicus Brief NOVO NORDISK v Cochran Re 340B Contract Pharmacy – Intervention Filed June 22, 2021

Amicus Brief NOVO NORDISK v Cochran Re 340B Contract Pharmacy – Intervention
Public

Amicus Brief Eli Lilly v Cochran Re 340B Contract Pharmacy – Intervention - Filed June 23, 2021

Amicus Brief Eli Lilly v Cochran Re 340B Contract Pharmacy – Intervention filed June 23, 2021.

An Innovative Approach to Emergency Mental Health Care

EmPATH — or Emergency Psychiatric Assessment, Treatment and Healing — is designed to guide patients safely through a current crisis while building coping skills that will guide them through future challenges. Though it just opened in March, this unit is moving emergency mental health care in a new and exciting direction.

Lewis Zeidner, Ph.D.

Member

340B Advocacy Alliance Bulletin: 340B News, Podcast and Call Replay

HRSA will continue enforcement actions agains

Study: Early SARS-CoV-2 infections far exceeded diagnosed cases

An estimated 16.8 million U.S. adults had undiagnosed COVID-19 by July 2020, representing 4.6% of U.S. adults and 4.8 undiagnosed infections for every diagnosed case, according to a National Institutes of Health study published by the journal Science Translational Medicine. NIH’s SARS-CoV-2 Seroprevalence Project used an enzyme-linked immunosorbent assay to identify SARS-CoV-2 antibodies in dried blood samples collected from a representative sample of U.S. adults.